Prostate cancer
Results
Phase 2
This trial looked at adding a drug called capivasertib to chemotherapy to see how well it worked for prostate cancer.
It was for men whose cancer:
had spread to another part of the body (advanced cancer)
wasn’t responding to
The trial was supported by Cancer Research UK.
This trial was open for people to join between 2015 and 2019. The team published the results in 2020.
Recruitment start: 10 September 2015
Recruitment end: 31 January 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Simon Crabb
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University Hospital Southampton NHS Foundation Trust
This is Cancer Research UK trial number CRUK/12/042.
Last reviewed: 7 July 2021
CRUK internal database number: 10556
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
